Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-20 4:30 pm Purchase | 13G | REGULUS THERAPEUTICS INC P RGLS | Vivo Opportunity Fund Holdings L.P. | 5,000,000 7.7% | 5,000,000 (New Position) | View |
| 2024-02-14 4:30 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Vivo Opportunity Fund Holdings L.P. | 15,000,000 7.2% | 15,000,000 (New Position) | View |
| 2024-02-13 5:05 pm Sale | 13G | CLENE INC CLNN | Vivo Opportunity Fund Holdings L.P. | 12,500,000 7% | -5,237,800 (-29.53%) | View |
| 2024-02-13 5:00 pm Sale | 13G | DELCATH SYS INC DCTH | Vivo Opportunity Fund Holdings L.P. | 2,708,579 9.99% | -2,172,162 (-44.50%) | View |
| 2024-02-13 5:00 pm Unchanged | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | Vivo Opportunity Fund Holdings L.P. | 38,152,030 7.7% | 0 (Unchanged) | View |
| 2024-02-13 5:00 pm Unchanged | 13G | REZOLUTE INC RZLT | Vivo Opportunity Fund Holdings L.P. | 3,242,842 8.2% | 0 (Unchanged) | View |
| 2023-10-13 4:30 pm Purchase | 13G | REZOLUTE INC RZLT | Vivo Opportunity Fund Holdings L.P. | 3,242,842 8.8% | 3,242,842 (New Position) | View |
| 2023-10-11 4:30 pm Unchanged | 13D | SOLENO THERAPEUTICS INC PA SLNO | Vivo Opportunity Fund Holdings L.P. | 8,418,093 30.5% | 0 (Unchanged) | View |
| 2023-08-25 4:31 pm Purchase | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | Vivo Opportunity Fund Holdings L.P. | 3,216,000 5.1% | 3,216,000 (New Position) | View |
| 2023-08-18 4:56 pm Purchase | 13G | GRACELL BIOTECHNOLOGIES INC SP GRCL | Vivo Opportunity Fund Holdings L.P. | 38,152,030 7.8% | 38,152,030 (New Position) | View |
| 2023-07-14 4:30 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Vivo Opportunity Fund Holdings L.P. | 59,961,729 9.99% | 59,961,729 (New Position) | View |
| 2023-06-28 4:30 pm Purchase | 13G | CLENE INC CLNN | Vivo Opportunity Fund Holdings L.P. | 17,737,800 9.99% | 17,737,800 (New Position) | View |
| 2023-06-22 4:30 pm Purchase | 13G | DELCATH SYS INC DCTH | Vivo Opportunity Fund Holdings L.P. | 4,880,741 9.99% | 4,880,741 (New Position) | View |
| 2023-06-01 5:00 pm Purchase | 13D | SOLENO THERAPEUTICS INC PA SLNO | Vivo Opportunity Fund Holdings L.P. | 8,418,093 50.8% | 8,418,093 (New Position) | View |
| 2023-05-15 5:02 pm Purchase | 13G | SOLENO THERAPEUTICS INC NE SLNO | Vivo Opportunity Fund Holdings L.P. | 8,418,093 19.99% | 8,418,093 (New Position) | View |